Endo International PLC (ENDP)
|Net Income (ttm)||-726.74M|
|Day's Range||0.520 - 0.710|
|52-Week Range||0.280 - 7.070|
|Price Target||1.36 (+144.4%)|
|Earnings Date||Aug 4, 2022|
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PE... [Read more...]
Financial PerformanceFinancial Statements
According to 10 analysts, the average rating for ENDP stock is "Sell." The 12-month stock price forecast is 1.36, which is an increase of 144.38% from the latest price.
Endo International has been surging all day but it isn't just Plan B that has kept it rising. Here's why ENDP stock is a name to watch.
Penny stocks to watch with news The post Penny Stocks To Watch: Why TOUR, JAN, ENDP, BRDS & WEJO Stock Are Moving appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Check these three biotech penny stocks out for your watchlist right now The post 3 Biotech Penny Stocks That Climbed in After-Hours Trading appeared first on Penny Stocks to Buy, Picks, News and Informa...
Here's what you need to know about trading penny stocks on June 15th The post What to Know About Buying Penny Stocks on June 15th appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...
Endo (ENDP) collaborates with Taiwan Liposome to commercialize TLC599, an extended and controlled release liposomal formulated dexamethasone for chronic knee osteoarthritis (OA) pain.
Here's what you need to know about trading penny stocks on June 14th The post What to Know About Trading Penny Stocks on June 14th appeared first on Penny Stocks to Buy, Picks, News and Information | P...
Endo Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee...
DUBLIN , June 13, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) has executed an agreement with Taiwan Liposome Company, Ltd. ...
Can these penny stocks climb this coming month? The post Penny Stocks to Add to Your Watchlist Next Week, 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Here are three penny stocks to watch after today's bullish session The post Top Penny Stocks to Watch After a Bullish Trading Day appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...
Endo (ENDP) plunges on reports of negotiations with its lenders and senior bondholders about a possible restructuring of more than $8 billion of debt.
Reports that the specialty pharmaceutical company is looking to restructure debt prompted the drop.
Endo International Plc (NASDAQ: ENDP) initiated negotiations with its lenders and senior bondholders regarding a possible reorganization of more than $8 billion of its debt, the Wall Street Journal repo...
Buxton Helmsley Issues Letter to Endo International Plc. Shareholders and Creditors, Relating to Corporate Malfeasanc...
NEW YORK--(BUSINESS WIRE)--The Buxton Helmsley Group, Inc. (together with certain of its affiliates and clients, “BHG” or “we”), the New York City-based investment advisor to clients with financial inte...
Endo (ENDP) tops Q1 earnings and sales estimates. However, Vasostrict faces generic competition and the guidance for Q2 is dismal.
Endo International plc's (NASDAQ: ENDP) Q1 sales decreased 9% to $652.26 million, beating the consensus of $633.41 million. The decrease was attributable to decreased revenues from the sterile injectabl...
The company provided disappointing Q2 guidance.
Endo International PLC (NASDAQ: ENDP) shares are trading lower by 34.65% at $1.32 after the company reported first-quarter earnings results and issued second-quarter guidance. Endo International reporte...
Endo (ENDP) delivered earnings and revenue surprises of 50% and 1.73%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
DUBLIN , May 5, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter 2022 financial guidance...
Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCA...
DUBLIN , May 5, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the upcoming launch of a new clinical study relevant to the use of Qwo® (collagenase clostridium histolyticum-a...
Let's look at the five biotech/drug companies, slated to release quarterly results on May 5.
Endo (ENDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
DUBLIN , May 2, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) acquired six development-stage, ready-to-use injectable product...